These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 19076131

  • 21. Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.
    Iizuka J, Kondo T, Hashimoto Y, Kobayashi H, Ikezawa E, Takagi T, Omae K, Tanabe K.
    Int J Urol; 2012 Nov; 19(11):980-6. PubMed ID: 22735049
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN, Weight CJ, Gill IS.
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [Abstract] [Full Text] [Related]

  • 24. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG.
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
    Boulière F, Crepel M, Bigot P, Pignot G, Bessede T, de la Taille A, Salomon L, Tostain J, Bellec L, Soulié M, Rischmann P, Bernhard JC, Ferrière JM, Pfister C, Albouy B, Colombel M, Zini L, Villers A, Rigaud J, Bouchot O, Patard JJ.
    Prog Urol; 2011 Nov; 21(12):842-50. PubMed ID: 22035910
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival.
    Weight CJ, Larson BT, Gao T, Campbell SC, Lane BR, Kaouk JH, Gill IS, Klein EA, Fergany AF.
    Urology; 2010 Sep; 76(3):631-7. PubMed ID: 20451967
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Operative mortality after nephrectomy for renal cell carcinoma.
    Thoroddsen A, Gudbjartsson T, Jonsson E, Gislason T, Einarsson GV.
    Scand J Urol Nephrol; 2003 Sep; 37(6):507-11. PubMed ID: 14675926
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [Abstract] [Full Text] [Related]

  • 37. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC.
    Cancer; 2018 Oct 01; 124(19):3839-3848. PubMed ID: 30207380
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
    Zini L, Capitanio U, Perrotte P, Jeldres C, Shariat SF, Arjane P, Widmer H, Montorsi F, Patard JJ, Karakiewicz PI.
    Urology; 2009 Feb 01; 73(2):342-6. PubMed ID: 19041122
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.